FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G with the SEC on November 4, 2026, disclosing their beneficial ownership of common stock in Twist Bioscience Corp as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported 9,535,192.79 shares of Twist Bioscience Corp common stock beneficially owned.
  • Percent of class: The aggregate position represents 14.4% of Twist Bioscience Corp's outstanding common stock as of September 30, 2026.
  • Sole voting power (FMR LLC): FMR LLC reported sole voting power over 9,519,320.88 shares, with 0.00 shares subject to shared voting power.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson reported sole dispositive power over 9,535,192.79 shares, with no shared dispositive power.
  • Subsidiary interest disclosed: Fidelity Global Innovators Investment Trust held 3,476,508.00 shares, amounting to 5.2% of total outstanding common stock, according to the filing.
  • Triggering event date: The date of the event requiring this filing was September 30, 2026.

FMR LLC and Abigail P. Johnson Disclose Ownership Position in Twist Bioscience as of September 30, 2026

According to the Schedule 13G Amendment No. 2 filed on November 4, 2026, FMR LLC, a Delaware-organized holding company with its principal business office at 245 Summer Street, Boston, Massachusetts 02210, reported an aggregate beneficial ownership of 9,535,192.79 shares of Twist Bioscience Corp (NASDAQ:TWST) common stock (CUSIP 90184D100). The filing identified FMR LLC as a parent holding company or control person under Rule 13d-1(b)(1)(ii)(G).

Abigail P. Johnson, a United States citizen, is also listed as a reporting person in the same filing. She reported the identical aggregate beneficial ownership figure of 9,535,192.79 shares, all attributable to sole dispositive power, with no sole or shared voting power reported for her individually. The filing disclosed that one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the common stock. Specifically, Fidelity Global Innovators Investment Trust's interest in Twist Bioscience Corp common stock amounted to 3,476,508.00 shares, or 5.2% of total outstanding common stock as of September 30, 2026.

The filing was signed by Stephanie J. Brown, acting as duly authorized agent under separate powers of attorney on behalf of both FMR LLC and Abigail P. Johnson. The certification included in the filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G disclosing combined beneficial ownership of 9,535,192.79 shares, equal to 14.4% of Twist Bioscience Corp's common stock, as of September 30, 2026, with Fidelity Global Innovators Investment Trust holding 3,476,508.00 shares within that total.